Task: Answer the multiple-choice question.
Question: Which drug has a -55.996% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a CCO[C@@H]1OC(C(=O)N2CCOCC2)=C[C@H](c2ccccc2)[C@H]1CCCO
b CCOc1ccc(C(=O)Nc2ccc(CN3CCOCC3)cc2)cc1Cl
Answer: b. CCOc1ccc(C(=O)Nc2ccc(CN3CCOCC3)cc2)cc1Cl
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCOc1ccc(C(=O)Nc2ccc(CN3CCOCC3)cc2)cc1Cl
CCOc1ccc(C(=O)Nc2ccc(CN3CCOCC3)cc2)cc1Cl
3-chloro-4-ethoxy-N-[4-(morpholin-4-ylmethyl)phenyl]benzamide